Alzabistat (Alzaclear)
Product detail for Alzabistat, INN: alzabistat. Therapeutic area: Neurology. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-008
INN
alzabistat
Therapeutic Area
Neurology
Status
Active
Owner
Marcus Webb
Created
2022-07-23
Last Updated
2024-01-10
Markets
9
Presentations
| Form | Strength | Route |
|---|---|---|
| Transdermal patch | 2.5 mg | Intravitreal |
| Oral solution | 40 mg/0.4 mL | Intravitreal |
| Powder for injection | 100 mg | Intramuscular |
| Inhalation powder | 10 mg/mL | Subcutaneous |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-008 | Alzabistat | alzabistat | 55813-84-2 | biologic | Active |
| SUB-023 | Upadacitimab | upadacitimab | 75138-41-9 | small-molecule | Active |
Applications (4)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| MHRA-2022-0008 | United Kingdom | sMAA | Draft | James O'Brien | 2022-08-05 |
| SAHPRA-2022-0038 | United Kingdom | sBLA | Submitted | James O'Brien | 2023-11-02 |
| MHRA-2022-0068 | United Kingdom | BLA | Approved | Dmitri Volkov | 2023-01-23 |
| SAHPRA-2022-0098 | United Kingdom | sMAA | Pending | Sarah Chen | 2024-03-24 |
Markets (9)